Target intelligence / Profile preview

Cysteine and glycine-rich protein 2 (CSRP2)

Target
CSRP2
Molecular classification
Other (LIM domain-containing protein; not a classical receptor, enzyme, transporter, or transcription factor)
01

Overview

Cysteine and glycine-rich protein 2 (CSRP2) is a LIM domain–containing protein that plays critical roles in modulating cytoskeletal organization, cell adhesion, and cell motility[1][4]. CSRP2 is part of a small gene family (with CSRP1 and CSRP3) and features two LIM zinc-binding domains. It is implicated in cellular differentiation and development, particularly in muscle cells and vascular tissues[3][4]. In pathological settings, CSRP2 supports formation of actin-rich invadopodia in cancer cells, facilitating extracellular matrix degradation and cell invasion during hypoxia. Its downregulation can promote proliferation and invasion in some cancers, while its upregulation is linked to increased risk of relapse in B-cell acute lymphoblastic leukemia, highlighting context-dependent roles in cancer progression and vascular remodeling[1][4]. There are no established drugs that directly target CSRP2, and it is not considered a therapeutic target (receptor, enzyme, transporter, etc.) at present[4].

Other names
CRP2LMO5SmLIMLIM domain only protein 5Smooth muscle cell LIM proteinCysteine-rich protein 2LIM domain only 5, smooth muscleEpididymis secretory sperm binding protein
02

Biological functions

Cytoskeletal organizationCell–cell adhesionCell motility and migrationCellular differentiationMuscle tissue developmentSarcomere organization
03

Disease associations

Cancer (breast, colorectal, B-cell acute lymphoblastic leukemia)Cardiovascular disease (vascular remodeling, smooth muscle cell migration)
04

Biomarkers

Prognostic marker for relapse-free survival in B-cell acute lymphoblastic leukemia[1]

Beyond the preview

Go deeper on Cysteine and glycine-rich protein 2 (CSRP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine and glycine-rich protein 2 (CSRP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call